Early safety data, an mRNA-encoded VLP design and a promise of open release. What the PVX-001 announcement supports, and the open questions it leaves.
Share this article
Covid-19 vaccineOpen SourcePVX-001Phase 1 trialPopVaxmRNA VLP vaccine
Early safety data, an mRNA-encoded VLP design and a promise of open release. What the PVX-001 announcement supports, and the open questions it leaves.
Share this article
Comments